John M. Kovarik
Novartis Pharma AG
Basel
Switzerland
Name/email consistency: high
- Effect of multiple-dose erythromycin on everolimus pharmacokinetics. Kovarik, J.M., Beyer, D., Bizot, M.N., Jiang, Q., Shenouda, M., Schmouder, R.L. Eur. J. Clin. Pharmacol. (2005)
- Pharmacokinetic interaction between verapamil and everolimus in healthy subjects. Kovarik, J.M., Beyer, D., Bizot, M.N., Jiang, Q., Allison, M.J., Schmouder, R.L. Br. J. Clin. Pharmacol (2005)
- Everolimus: a proliferation signal inhibitor targeting primary causes of allograft dysfunction. Kovarik, J.M. Drugs. Today (2004)
- Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects. Kovarik, J.M., Schmouder, R., Barilla, D., Wang, Y., Kraus, G. Br. J. Clin. Pharmacol (2004)
- FTY720 and cyclosporine: evaluation for a pharmacokinetic interaction. Kovarik, J.M., Schmouder, R.L., Barilla, D., Büche, M., Rouilly, M., Berthier, S., Wang, Y., Van Saders, C., Mayer, T., Gottlieb, A.B. Ann. Pharmacother (2004)
- Overview of FTY720 clinical pharmacokinetics and pharmacology. Kovarik, J.M., Schmouder, R.L., Slade, A.J. Ther. Drug. Monit (2004)
- Pharmacokinetics of an everolimus-cyclosporine immunosuppressive regimen over the first 6 months after kidney transplantation. Kovarik, J.M., Kaplan, B., Silva, H.T., Kahan, B.D., Dantal, J., McMahon, L., Berthier, S., Hsu, C.H., Rordorf, C. Am. J. Transplant. (2003)
- Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure. Kovarik, J.M., Eisen, H., Dorent, R., Mancini, D., Vigano, M., Rouilly, M., Hsu, C.H., Rordorf, C. J. Heart Lung Transplant. (2003)
- Cyclosporine absorption profiles in pediatric kidney and liver transplant patients. Kovarik, J.M., Hoyer, P.F., Ettenger, R., Punch, J., Soergel, M. Pediatr. Nephrol. (2003)
- Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases. Kovarik, J.M., Burtin, P. Expert. Opin. Emerg. Drugs (2003)
- Influence of delayed initiation of cyclosporine on everolimus pharmacokinetics in de novo renal transplant patients. Kovarik, J.M., Dantal, J., Civati, G., Rizzo, G., Rouilly, M., Bettoni-Ristic, O., Rordorf, C. Am. J. Transplant. (2003)
- Effect of food on everolimus absorption: quantification in healthy subjects and a confirmatory screening in patients with renal transplants. Kovarik, J.M., Hartmann, S., Figueiredo, J., Rordorf, C., Golor, G., Lison, A., Budde, K., Neumayer, H.H. Pharmacotherapy (2002)
- Effect of rifampin on apparent clearance of everolimus. Kovarik, J.M., Hartmann, S., Figueiredo, J., Rouilly, M., Port, A., Rordorf, C. Ann. Pharmacother (2002)
- Administration diluents differentiate Neoral from a generic cyclosporine oral solution. Kovarik, J.M., Barilla, D., McMahon, L., Wang, Y., Kisicki, J., Schmouder, R. Clin. Transplant (2002)
- Basiliximab in pediatric liver transplantation: a pharmacokinetic-derived dosing algorithm. Kovarik, J.M., Gridelli, B.G., Martin, S., Rodeck, B., Melter, M., Dunn, S.P., Merion, R.M., Tzakis, A.G., Alonso, E., Bucuvalas, J., Sharp, H., Gerbeau, C., Chodoff, L., Korn, A., Hall, M. Pediatr. Transplant (2002)
- Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients. Kovarik, J.M., Pescovitz, M.D., Sollinger, H.W., Kaplan, B., Legendre, C., Salmela, K., Book, B.K., Gerbeau, C., Girault, D., Somberg, K. Clin. Transplant (2001)
- Screening for basiliximab exposure-response relationships in renal allotransplantation. Kovarik, J.M., Moore, R., Wolf, P., Abendroth, D., Landsberg, D., Soulillou, J.P., Gerbeau, C., Schmidt, A.G. Clin. Transplant (1999)
- Cyclosporin pharmacokinetics in the elderly. Kovarik, J.M., Koelle, E.U. Drugs. Aging (1999)
